Relative expression levels of the HLA class-I proteins in normal and HIV-infected cells

Journal of Immunology

Volumn 194, Issue 8, 2015, Pages 3594-3600

  Apps, Richard ^a   Meng, Zhaojing ^a   Del Prete, Gregory Q ^a   Lifson, Jeffrey D ^a   Zhou, Ming ^a   Carrington, Mary ^a,b  

^a FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE LOCUS; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; LEUKOCYTE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; FEMALE; GENE EXPRESSION REGULATION; IMMUNOLOGY; MALE; PATHOLOGY;

CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC LOCI; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HUMANS; MALE;

EID: 84927602620     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1403234     Document Type: Article

References (47)

1. Bashirova, A. A., R. Thomas, and M. Carrington. 2011. HLA/KIR restraint of HIV: surviving the fittest. Annu. Rev. Immunol. 29:295-317.
2. Gough, S. C. L., and M. J. Simmonds. 2007. The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action. Curr. Genomics 8:453-465.
3. Sasazuki, T., T. Juji, Y. Morishima, N. Kinukawa, H. Kashiwabara, H. Inoko, T. Yoshida, A. Kimura, T. Akaza, N. Kamikawaji, et al. 1998. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. N. Engl. J. Med. 339:1177-1185.
4. Campoli, M., and S. Ferrone. 2008. HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance. Oncogene 27:5869-5885.
5. Hiby, S. E., R. Apps, O. Chazara, L. E. Farrell, P. Magnus, L. Trogstad, H. K. Gjessing, M. Carrington, and A. Moffett. 2014. Maternal KIR in combination with paternal HLA-C2 regulate human birth weight. J. Immunol. 192:5069-5073.
6. Parham, P., C. E. Lomen, D. A. Lawlor, J. P. Ways, N. Holmes, H. L. Coppin, R. D. Salter, A. M. Wan, and P. D. Ennis. 1988. Nature of polymorphism in HLA-A, -B, and -C molecules. Proc. Natl. Acad. Sci. USA 85:4005-4009.
7. Lee, N., M. Llano, M. Carretero, A. Ishitani, F. Navarro, M. López-Botet, and D. E. Geraghty. 1998. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 95:5199-5204.
8. Koeffler, H. P., J. Ranyard, L. Yelton, R. Billing, and R. Bohman. 1984. Gammainterferon induces expression of the HLA-D antigens on normal and leukemic human myeloid cells. Proc. Natl. Acad. Sci. USA 81:4080-4084.
9. Schwartz, O., V. Maréchal, S. Le Gall, F. Lemonnier, and J. M. Heard. 1996. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2:338-342.
10. Jones, T. R., L. K. Hanson, L. Sun, J. S. Slater, R. M. Stenberg, and A. E. Campbell. 1995. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J. Virol. 69:4830-4841.
11. Bennett, E. M., J. R. Bennink, J. W. Yewdell, and F. M. Brodsky. 1999. Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. J. Immunol. 162:5049-5052.
12. Ishido, S., C. Wang, B. S. Lee, G. B. Cohen, and J. U. Jung. 2000. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 74:5300-5309.
13. Apps, R., Y. Qi, J. M. Carlson, H. Chen, X. Gao, R. Thomas, Y. Yuki, G. Q. Del Prete, P. Goulder, Z. L. Brumme, et al. 2013. Influence of HLA-C expression level on HIV control. Science 340:87-91.
14. Thomas, R., R. Apps, Y. Qi, X. Gao, V. Male, C. O'hUigin, G. O'Connor, D. Ge, J. Fellay, J. N. Martin, et al. 2009. HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat. Genet. 41:1290-1294.
15. Fellay, J., K. V. Shianna, D. Ge, S. Colombo, B. Ledergerber, M. Weale, K. Zhang, C. Gumbs, A. Castagna, A. Cossarizza, et al. 2007. A whole-genome association study of major determinants for host control of HIV-1. Science 317:944-947.
16. International HIV Controllers Study. 2010. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330:1551-1557.
17. Kulkarni, S., R. Savan, Y. Qi, X. Gao, Y. Yuki, S. E. Bass, M. P. Martin, P. Hunt, S. G. Deeks, A. Telenti, et al. 2011. Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472:495-498.
18. Kulkarni, S., Y. Qi, C. O'hUigin, F. Pereyra, V. Ramsuran, P. McLaren, J. Fellay, G. Nelson, H. Chen, W. Liao, et al. 2013. Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease. Proc. Natl. Acad. Sci. USA 110:20705-20710.
19. Snary, D., C. J. Barnstable, W. F. Bodmer, and M. J. Crumpton. 1977. Molecular structure of human histocompatibility antigens: the HLA-C series. Eur. J. Immunol. 7:580-585.
20. Apps, R., and M. Carrington. 2013. Response to Comment on "Influence of HLA-C expression level on HIV control". Science 341:1175.
21. Ravindranath, M. H., T. Pham, N. El-Awar, H. Kaneku, and P. I. Terasaki. 2011. Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies. Mol. Immunol. 48:423-430.
22. Collins, K. L., B. K. Chen, S. A. Kalams, B. D. Walker, and D. Baltimore. 1998. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391:397-401.
23. Swigut, T., L. Alexander, J. Morgan, J. Lifson, K. G. Mansfield, S. Lang, R. P. Johnson, J. Skowronski, and R. Desrosiers. 2004. Impact of Nef-mediated downregulation of major histocompatibility complex class I on immune response to simian immunodeficiency virus. J. Virol. 78:13335-13344.
24. Zaunders, J., W. B. Dyer, and M. Churchill. 2011. The Sydney Blood Bank Cohort: implications for viral fitness as a cause of elite control. Curr Opin HIV AIDS 6:151-156.
25. Cohen, G. B., R. T. Gandhi, D. M. Davis, O. Mandelboim, B. K. Chen, J. L. Strominger, and D. Baltimore. 1999. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10:661-671.
26. Rajapaksa, U. S., D. Li, Y. C. Peng, A. J. McMichael, T. Dong, and X. N. Xu. 2012. HLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulation. Proc. Natl. Acad. Sci. USA 109:13353-13358.
27. Hansen, J. A. ed. 13th IHWS Technology Joint Report. 2006. Section A: HLA typing and Informatics. In Immunobiology of the Human MHC, Proceedings of the 13th International Histocompatibility Workshop and Conference. J. A. Hansen ed. IHWG Press, Seattle, WA. Vol. I, p. 179-480.
28. Apps, R., S. P. Murphy, R. Fernando, L. Gardner, T. Ahad, and A. Moffett. 2009. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 127:26-39.
29. Barnstable, C. J., W. F. Bodmer, G. Brown, G. Galfre, C. Milstein, A. F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 14:9-20.
30. Brodsky, F. M., W. F. Bodmer, and P. Parham. 1979. Characterization of a monoclonal anti-beta 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens. Eur. J. Immunol. 9:536-545.
31. Beretta, A., F. Grassi, M. Pelagi, A. Clivio, C. Parravicini, G. Giovinazzo, F. Andronico, L. Lopalco, P. Verani, S. Buttò, et al. 1987. HIV env glycoprotein shares a cross-reacting epitope with a surface protein present on activated human monocytes and involved in antigen presentation. Eur. J. Immunol. 17:1793-1798.
32. Parham, P., and W. F. Bodmer. 1978. Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2. Nature 276:397-399.
33. Tahara, T., S. Y. Yang, R. Khan, S. Abish, G. J. Hämmerling, and U. Hämmerling. 1990. HLA antibody responses in HLA class I transgenic mice. Immunogenetics 32:351-360.
34. Lutz, C. T., K. D. Smith, N. S. Greazel, B. E. Mace, D. A. Jensen, J. A. McCutcheon, and N. E. Goeken. 1994. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix. J. Immunol. 153:4099-4110.
35. Braud, V. M., D. S. Allan, D. Wilson, and A. J. McMichael. 1998. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 8:1-10.
36. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndromeassociated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
37. Morcock, D. R., J. A. Thomas, R. C. Sowder, II, L. E. Henderson, B. J. Crise, and R. J. Gorelick. 2008. HIV-1 inactivation by 4-vinylpyridine is enhanced by dissociating Zn (2+) from nucleocapsid protein. Virology 375:148-158.
38. + T-cells as target cells in natural killer cell cytotoxic assays. J. Vis. Exp. 49:e2668.
39. Zhou, M., D. A. Lucas, K. C. Chan, H. J. Issaq, E. F. Petricoin, III, L. A. Liotta, T. D. Veenstra, and T. P. Conrads. 2004. An investigation into the human serum "interactome". Electrophoresis 25:1289-1298.
40. Marozzi, A., R. Meneveri, C. De Santis, P. Robbioni, E. Molteni, A. Beretta, A. G. Siccardi, and E. Ginelli. 1996. Expression of distinct conformations of free HLA-Cw4 heavy chains in transfected neuroblastoma cells. Immunogenetics 43:289-295.
41. Jones, D. C., V. Kosmoliaptsis, R. Apps, N. Lapaque, I. Smith, A. Kono, C. Chang, L. H. Boyle, C. J. Taylor, J. Trowsdale, and R. L. Allen. 2011. HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. J. Immunol. 186:2990-2997.
42. Corrah, T. W., N. Goonetilleke, J. Kopycinski, S. G. Deeks, M. S. Cohen, P. Borrow, A. McMichael, and S. Brackenridge. 2011. Reappraisal of the relationship between the HIV-1-protective single-nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and surface HLA-C expression. J. Virol. 85:3367-3374.
43. ∗57 by primary human immunodeficiency virus type 1 isolates cultured from elite suppressors. J. Virol. 83:6941-6946.
44. Reits, E. A., J. W. Hodge, C. A. Herberts, T. A. Groothuis, M. Chakraborty, E. K. Wansley, K. Camphausen, R. M. Luiten, A. H. De Ru, J. Neijssen, et al. 2006. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J. Exp. Med. 203:1259-1271.
45. Faroudi, M., C. Utzny, M. Salio, V. Cerundolo, M. Guiraud, S. Müller, and S. Valitutti. 2003. Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: manifestation of a dual activation threshold. Proc. Natl. Acad. Sci. USA 100:14145-14150.
46. Kaufman, J., H. Vö Lk, and H. J. Wallny. 1995. A "minimal essential Mhc" and an "unrecognized Mhc": two extremes in selection for polymorphism. Immunol. Rev. 143:63-88.
47. Kaufman, J., and J. Salomonsen. 1997. The "minimal essential MHC" revisited: both peptide-binding and cell surface expression level of MHC molecules are polymorphisms selected by pathogens in chickens. Hereditas 127:67-73.